- Home
- EVAX vs ADXN Comparison
EVAX vs ADXN Comparison
Compare EVAX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVAX | ADXN |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | Denmark | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.7M | 10.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVAX | ADXN |
|---|---|---|
| Price | $4.92 | $8.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | ★ 108.8K | 7.2K |
| Earning Date | 11-06-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,650,000.00 | $198,824.00 |
| Revenue This Year | $128.77 | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 132.17 | N/A |
| 52 Week Low | $1.20 | $6.51 |
| 52 Week High | $12.15 | $12.05 |
Technical Indicators
Market Signals| Indicator | EVAX | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 42.56 | 50.09 |
| Support Level | $4.60 | $7.47 |
| Resistance Level | $6.70 | $8.30 |
| Average True Range (ATR) | 0.53 | 0.50 |
| MACD | -0.13 | 0.09 |
| Stochastic Oscillator | 13.79 | 60.10 |
Price Performance
Historical ComparisonAbout EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.